European Medicines Agency: Link Between AstraZeneca COVID Vaccine & Rare Blood Clots – But ‘Benefits Far Outweigh Risks’ 07/04/2021 Elaine Ruth Fletcher Following a second meeting of the EMA’s safety committee in as many weeks, the European Medicines Agency said that there appears to be a link between receipt of the AstraZeneca vaccine and very rare cases of blood clots being seen in some people – mainly younger women – within two weeks of their jab. The […] Continue reading -> Nigeria Pivots From AstraZeneca To Johnson & Johnson COVID-19 Vaccine 31/03/2021 Paul Adepoju EXCLUSIVE – IBADAN – The Nigerian government has quietly ditched the AstraZeneca COVID-19 vaccine meant to vaccinate tens of millions of citizens, and will gradually shift to the Johnson & Johnson’s one-shot vaccine, saying it is easier to administer. Documents from the Nigerian Primary Healthcare Development Agency (NPHCDA) obtained by Health Policy Watch show […] Continue reading -> Germany Suspends Use of AstraZeneca For Younger Population Over Reports of Rare Blood Cloth Cases 31/03/2021 Chandre Prince Germany has suspended the use of the AstraZeneca coronavirus vaccine for people under the age of 60 amidst fresh concerns of unusual blood clot cases among some people receiving the vaccine, particularly women, and leading to the deaths of nine people in all. German Chancellor Angela Merkel and Health Minister Jens Spahn made the announcement […] Continue reading -> US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Benefits of AstraZeneca Vaccine Outweigh Risks, Say EMA and WHO Officials – Urging Jabs to Continue as Safety Data Reviewed 12/03/2021 Madeleine Hoecklin Both the European Medicines Agency and the World Health Organization have urged that immunizations with the Oxford/AstraZeneca COVID-19 vaccine continue – despite a decision by several European countries to suspend its use – after reports of serious blood clots among 30 of the 5 million people vaccinated – leading to at least five deaths. An […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Nigeria Pivots From AstraZeneca To Johnson & Johnson COVID-19 Vaccine 31/03/2021 Paul Adepoju EXCLUSIVE – IBADAN – The Nigerian government has quietly ditched the AstraZeneca COVID-19 vaccine meant to vaccinate tens of millions of citizens, and will gradually shift to the Johnson & Johnson’s one-shot vaccine, saying it is easier to administer. Documents from the Nigerian Primary Healthcare Development Agency (NPHCDA) obtained by Health Policy Watch show […] Continue reading -> Germany Suspends Use of AstraZeneca For Younger Population Over Reports of Rare Blood Cloth Cases 31/03/2021 Chandre Prince Germany has suspended the use of the AstraZeneca coronavirus vaccine for people under the age of 60 amidst fresh concerns of unusual blood clot cases among some people receiving the vaccine, particularly women, and leading to the deaths of nine people in all. German Chancellor Angela Merkel and Health Minister Jens Spahn made the announcement […] Continue reading -> US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Benefits of AstraZeneca Vaccine Outweigh Risks, Say EMA and WHO Officials – Urging Jabs to Continue as Safety Data Reviewed 12/03/2021 Madeleine Hoecklin Both the European Medicines Agency and the World Health Organization have urged that immunizations with the Oxford/AstraZeneca COVID-19 vaccine continue – despite a decision by several European countries to suspend its use – after reports of serious blood clots among 30 of the 5 million people vaccinated – leading to at least five deaths. An […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Germany Suspends Use of AstraZeneca For Younger Population Over Reports of Rare Blood Cloth Cases 31/03/2021 Chandre Prince Germany has suspended the use of the AstraZeneca coronavirus vaccine for people under the age of 60 amidst fresh concerns of unusual blood clot cases among some people receiving the vaccine, particularly women, and leading to the deaths of nine people in all. German Chancellor Angela Merkel and Health Minister Jens Spahn made the announcement […] Continue reading -> US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Benefits of AstraZeneca Vaccine Outweigh Risks, Say EMA and WHO Officials – Urging Jabs to Continue as Safety Data Reviewed 12/03/2021 Madeleine Hoecklin Both the European Medicines Agency and the World Health Organization have urged that immunizations with the Oxford/AstraZeneca COVID-19 vaccine continue – despite a decision by several European countries to suspend its use – after reports of serious blood clots among 30 of the 5 million people vaccinated – leading to at least five deaths. An […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US Health Officials Question AstraZeneca’s Vaccine Trial a Day After Results Are Released 23/03/2021 Raisa Santos British-Swedish pharma company AstraZeneca may have included outdated information from their COVID-19 vaccine trial, the US National Institute of Allergy and Infectious Diseases (NIAID) said in a statement released Tuesday. The NIAID, part of the National Institutes of Health, urged AstraZeneca to work with the US Data Safety and Monitoring Board (DSMB) to review the […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Benefits of AstraZeneca Vaccine Outweigh Risks, Say EMA and WHO Officials – Urging Jabs to Continue as Safety Data Reviewed 12/03/2021 Madeleine Hoecklin Both the European Medicines Agency and the World Health Organization have urged that immunizations with the Oxford/AstraZeneca COVID-19 vaccine continue – despite a decision by several European countries to suspend its use – after reports of serious blood clots among 30 of the 5 million people vaccinated – leading to at least five deaths. An […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Benefits of AstraZeneca Vaccine Outweigh Risks, Say EMA and WHO Officials – Urging Jabs to Continue as Safety Data Reviewed 12/03/2021 Madeleine Hoecklin Both the European Medicines Agency and the World Health Organization have urged that immunizations with the Oxford/AstraZeneca COVID-19 vaccine continue – despite a decision by several European countries to suspend its use – after reports of serious blood clots among 30 of the 5 million people vaccinated – leading to at least five deaths. An […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sputnik V Vaccine Developers Expand The Global Production Network; EU To Resolve Supply Dispute With AstraZeneca 19/03/2021 Madeleine Hoecklin Developers of Russia’s Sputnik V vaccine have entered into a partnership with Stelis Biopharma, an India-based drugmaker, to produce 200 million doses of the COVID-19 vaccine. Stelis is now the latest addition to the global production network for Sputnik V. The Russian Direct Investment Fund (RDIF), the company responsible for marketing the Sputnik vaccine abroad, […] Continue reading -> European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Benefits of AstraZeneca Vaccine Outweigh Risks, Say EMA and WHO Officials – Urging Jabs to Continue as Safety Data Reviewed 12/03/2021 Madeleine Hoecklin Both the European Medicines Agency and the World Health Organization have urged that immunizations with the Oxford/AstraZeneca COVID-19 vaccine continue – despite a decision by several European countries to suspend its use – after reports of serious blood clots among 30 of the 5 million people vaccinated – leading to at least five deaths. An […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible Rare Events 18/03/2021 Elaine Ruth Fletcher The European Medicines Agency’s safety committee (PRAC) on Thursday gave a resounding endorsement of the Oxford/AstraZeneca vaccine against COVID-19, concluding that the vaccine’s benefits vaccine “far outweigh” any risks – despite a possible link between some vaccinations and rare cases of blood clotting associated with low levels of blood platelets. The EMA statement followed two […] Continue reading -> European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Benefits of AstraZeneca Vaccine Outweigh Risks, Say EMA and WHO Officials – Urging Jabs to Continue as Safety Data Reviewed 12/03/2021 Madeleine Hoecklin Both the European Medicines Agency and the World Health Organization have urged that immunizations with the Oxford/AstraZeneca COVID-19 vaccine continue – despite a decision by several European countries to suspend its use – after reports of serious blood clots among 30 of the 5 million people vaccinated – leading to at least five deaths. An […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
European Union Sharply Divided Over AstraZeneca Rollout – Despite Lack Of Documented Link to Higher Blood Clot Risks 16/03/2021 Raisa Santos Major European nations remain divided over the use of Oxford/AstraZeneca’s COVID-19 vaccine, while the pharma company said there was no evidence of increased risk of blood clotting and abnormal bleeding among people who get the vaccine. AstraZeneca’s review of all the safety data of more than 17 million people vaccinated in the European Union (EU) […] Continue reading -> Benefits of AstraZeneca Vaccine Outweigh Risks, Say EMA and WHO Officials – Urging Jabs to Continue as Safety Data Reviewed 12/03/2021 Madeleine Hoecklin Both the European Medicines Agency and the World Health Organization have urged that immunizations with the Oxford/AstraZeneca COVID-19 vaccine continue – despite a decision by several European countries to suspend its use – after reports of serious blood clots among 30 of the 5 million people vaccinated – leading to at least five deaths. An […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Benefits of AstraZeneca Vaccine Outweigh Risks, Say EMA and WHO Officials – Urging Jabs to Continue as Safety Data Reviewed 12/03/2021 Madeleine Hoecklin Both the European Medicines Agency and the World Health Organization have urged that immunizations with the Oxford/AstraZeneca COVID-19 vaccine continue – despite a decision by several European countries to suspend its use – after reports of serious blood clots among 30 of the 5 million people vaccinated – leading to at least five deaths. An […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy